# NAR-submission
These files are of 2 types:
- mRNA-Seq from cells treated in early (Timepoint 1, TP1) and mid S-phase (Timepoint 2, TP2) for 1h with the transcription elongation inhibitors DRB and a-Amanitin; there 3 replicates for each timepoint for each condition plus DMSO treated samples as controls;
- BrdU-Seq of cells treated in early S-phase for 1h with the transcription inhibitors DRB and a-Amanitin; there are 2 replicates for each condition.
